| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w20889 |
| 来源ID | Working Paper 20889 |
| Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules | |
| Pierre Azoulay; Joshua S. Graff Zivin; Danielle Li; Bhaven N. Sampat | |
| 发表日期 | 2015-01-26 |
| 出版年 | 2015 |
| 语种 | 英语 |
| 摘要 | We quantify the impact of scientific grant funding at the National Institutes of Health (NIH) on patenting by pharmaceutical and biotechnology firms. Our paper makes two contributions. First, we use newly constructed bibliometric data to develop a method for flexibly linking specific grant expenditures to private-sector innovations. Second, we take advantage of idiosyncratic rigidities in the rules governing NIH peer review to generate exogenous variation in funding across research areas. Our results show that NIH funding spurs the development of private-sector patents: a $10 million boost in NIH funding leads to a net increase of 2.3 patents. Though valuing patents is difficult, we report a range of estimates for the private value of these patents using different approaches. |
| 主题 | Development and Growth ; Innovation and R& ; D |
| URL | https://www.nber.org/papers/w20889 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/578564 |
| 推荐引用方式 GB/T 7714 | Pierre Azoulay,Joshua S. Graff Zivin,Danielle Li,et al. Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules. 2015. |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
